Achieve Life Sciences announced the appointment of Dr. Mark L. Rubinstein as its new Head of Medical Affairs. Prior to joining Achieve, Dr. Rubinstein served as the Head of Medical Affairs at Blip, where he spearheaded the company’s strategy to help smokers and vapers quit through FDA-approved medications and digital support tools.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACHV:
- Achieve Life Sciences initiated with a Strong Buy at Raymond James
- Achieve Life Sciences Announces Leadership Shake-Up and Board Reshuffle
- Achieve Life Sciences CEO John Bencich to leave role, Richard Stewart to succeed
- Achieve Life Sciences reports Q2 EPS (25c), consensus (23c)
- Is ACHV a Buy, Before Earnings?